Veracyte VCYT
NASDAQ VCYT
$45.24 +0.95 (+2.14%)
As of: Aug 27, 2026 · 3:59 PM EDT

Veracyte (VCYT) Notes Payables (2012 - 2013)

Veracyte (VCYT) posted quarterly Notes Payables of $2.7 million for Q2 2013, up 350.0% on a QoQ basis from $600000.0 in Q4 2012.

Veracyte (VCYT) Notes Payables (2012 - 2013) Analysis & Trends

Veracyte has reported Notes Payables for 2 years, with the latest figure at $2.7 million in Q2 2013.

  • Notes Payables for Q2 2013 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2013 was $2.7 million (changed N/A YoY), and the FY2012 annual result was $600000.0, changed N/A from the prior year.
  • Notes Payables improved to $2.7 million in Q2 2013, from $600000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $2.7 million in Q2 2013 and troughed at $600000.0 in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Veracyte 3.62 Bn 3.32 Bn 108.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2013 2.70 Mn
Dec 31, 2012 600,000.00